Ani Pharmaceuticals Inc SEC filings ANIP

Ani Pharmaceuticals Inc has 1,002 filings in SEC EDGAR's recent list, going back to Nov 3, 2014. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Ani Pharmaceuticals Inc SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 9, 2026 Dec 31, 2025
10-K Annual report Feb 27, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 10, 2025 Dec 31, 2024
10-K Annual report Feb 28, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 5, 2024 Dec 31, 2023
10-K Annual report Feb 29, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 11, 2023 Dec 31, 2022
10-K Annual report Mar 9, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
10-K Annual report Mar 11, 2021 Dec 31, 2020
10-K Annual report Feb 27, 2020 Dec 31, 2019
10-K Annual report Feb 27, 2019 Dec 31, 2018
10-K Annual report Feb 27, 2018 Dec 31, 2017
10-K Annual report Mar 2, 2017 Dec 31, 2016
10-K Annual report Feb 23, 2016 Dec 31, 2015
10-K Annual report Feb 23, 2015 Dec 31, 2014

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ANIP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Large accelerated filer
SEC CIK
1023024
Former names
BIOSANTE PHARMACEUTICALS INC (until Jul 18, 2013); BEN ABRAHAM TECHNOLOGIES INC (until Dec 23, 1999)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.